Related references
Note: Only part of the references are listed.TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions
Michael D. Gallagher et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia
Marka van Blitterswijk et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in Han Chinese
Rui-Chun Lu et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function
Owen A. Brady et al.
HUMAN MOLECULAR GENETICS (2013)
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia
Alexandra M. Nicholson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain
Johanna I. Busch et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways
Alice S. Chen-Plotkin et al.
JOURNAL OF NEUROSCIENCE (2012)
TMEM106B RISK VARIANT IS IMPLICATED IN THE PATHOLOGIC PRESENTATION OF ALZHEIMER DISEASE
Nicola J. Rutherford et al.
NEUROLOGY (2012)
Regulation of Progranulin Expression in Human Microglia and Proteolysis of Progranulin by Matrix Metalloproteinase-12 (MMP-12)
Hyeon-Sook Suh et al.
PLOS ONE (2012)
Dystrophic neurites express C9orf72 in Alzheimer's disease brains
Jun-ichi Satoh et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis
Ryan Vass et al.
ACTA NEUROPATHOLOGICA (2011)
Progranulin Is a Chemoattractant for Microglia and Stimulates Their Endocytic Activity
Fiona Pickford et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
Julie van der Zee et al.
BRAIN (2011)
TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration
Julie van der Zee et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis
Marco Vercellino et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
N. Finch et al.
NEUROLOGY (2011)
Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles
K. E. Funk et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions
Vivianna M. Van Deerlin et al.
NATURE GENETICS (2010)
Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin
Fenghua Hu et al.
NEURON (2010)
Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models
Sandra Pereson et al.
JOURNAL OF PATHOLOGY (2009)
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Zeshan Ahmed et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
Identification of hippocampus-related candidate genes for Alzheimer's disease
K Taguchi et al.
ANNALS OF NEUROLOGY (2005)
Share Paper
